Rheumatic Heart Disease Global Market Report 2025: Key Players, Trends, and Growth Opportunities Unveiled

The Business Research Company's Rheumatic Heart Disease Global Market Report 2025: Key Players, Trends, and Growth Opportunities Unveiled

LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034.

What Is The Forecasted Growth Of The Rheumatic Heart Disease Market?
The rheumatic heart disease market has shown significant growth in recent years, expanding from $2.56 billion in 2024 to an anticipated $2.72 billion in 2025, demonstrating a compound annual growth rate CAGR of 6.3%. The existing growth can be primarily attributed to the prevalence of untreated strep infections, minimal access to healthcare in low-income regions, ignorance to rheumatic heart disease, delayed diagnosis and treatment, and inadequate vaccination programs.

What Is The Projected Market Size Of Rheumatic Heart Disease In The Next Few Years?
Over the next few years, the rheumatic heart disease market size is predicted to witness robust growth, reaching $3.44 billion in 2029 at a CAGR of 6.0%. This growth during the forecast period can largely be attributed to increasing adoption of preventive screening programs, growing awareness about early detection, a rise in healthcare investments in developing regions, expansion of telemedicine for remote diagnosis, and government initiatives for disease prevention. Major trends propelling this growth include increasing use of AI in diagnostics, expansion of echocardiography-based screening, integration of mobile health solutions, development of novel anti-inflammatory therapies, and collaborations for global disease eradication.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp

What Forces Are Behind The Forecasted Growth Of The Rheumatic Heart Disease Market?
Strep throat, a bacterial infection caused by streptococcus pyogenes group a streptococcus, leads to inflammation and throat pain and often comes with fever, swollen lymph nodes, and difficulty swallowing. The rising prevalence of strep throat is a critical factor propelling the growth of the rheumatic heart disease market. As antibiotic resistance continues to make streptococcal infections increasingly difficult to treat effectively, communities see higher transmission rates and longer periods of illness. Rheumatic heart disease often develops as a consequence of untreated or recurrent strep throat infections, emphasizing the importance of early diagnosis and effective treatment of streptococcal infections to prevent severe heart damage.

For instance, in April 2023, the Centers for Disease Control and Prevention reported an estimated 5.2 million outpatient visits annually from individuals younger than 65 years old due to strep throat. These visits resulted in 2.8 million antibiotic prescriptions each year. As such, the rising prevalence of strep throat is a key driver for the growth of the rheumatic heart disease market.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report

Who Are The Key Players In The Rheumatic Heart Disease Market?
Major companies operating in the rheumatic heart disease market include Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc GSK, Medtronic plc, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company BD, GE HealthCare Technologies Inc., Mayo Clinic, Boston Scientific Corporation, Johns Hopkins Medicine, Terumo Corporation, The Mount Sinai Health System Inc., Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, and Medanta.

Strategic Collaborations And Innovations: The Way Forward?
Major companies operating in the rheumatic heart disease market are now adopting a strategic partnership approach to develop innovative treatments and diagnoses and management of rheumatic heart disease. This method brings together resources and expertise which aids in research and development, improve diagnostic and therapeutic innovations, expand market penetration, and expedite commercialization. For instance, in July 2023, the World Heart Federation partnered with the Philips Foundation to enhance awareness, medical training, and early detection of rheumatic heart disease RHD in the Asia-Pacific APAC region.

How Is The Rheumatic Heart Disease Market Segmented?
The rheumatic heart disease market report covers diverse segments:

1. By Type: Valve, Myocarditis, Pericarditis
2. By Age Group: Pediatric, Adolescent, Adult, Geriatric
3. By Application: Hospital, Diagnostic Centre, Research Centre
4. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

Subsegments:
1. By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease
2. By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis
3. By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

What Are The Regional Insights Into The Rheumatic Heart Disease Market

In 2024, North America was the largest region in the rheumatic heart disease market. Other regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Hearth Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hearth-global-market-report
Prosthetic Heart Valve Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report
Heart Attack Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X